Reactivation of Coccidioidomycosis Despite Antifungal Prophylaxis in Solid Organ Transplant Recipients

被引:27
|
作者
Keckich, David W. [2 ]
Blair, Janis E. [1 ]
Vikram, Holenarasipur R. [1 ]
Seville, Maria Teresa [1 ]
Kusne, Shimon [1 ]
机构
[1] Mayo Clin, Div Infect Dis, Scottsdale, AZ 85259 USA
[2] Mayo Clin, Div Hosp Internal Med, Scottsdale, AZ USA
关键词
Coccidioides; Coccidioidomycosis; Prophylaxis; Solid organ reactivation; Transplantation; RENAL-TRANSPLANTATION; LIVER-TRANSPLANTATION; THERAPY; IMMUNOSUPPRESSION;
D O I
10.1097/TP.0b013e31821c1df6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Coccidioidomycosis is an airborne infection caused by the fungus Coccidioides, which is endemic to the southwestern United States. Cell-mediated immunity is required for the control of this infection, and some patients such as organ transplant recipients, who lack such immunity, have a high risk of severe, disseminated, or relapsed infection with high mortality. Previously latent coccidioidal infection can reactivate after transplantation. Antifungal prophylaxis has substantially decreased the risk of reactivated coccidioidomycosis after transplantation in these patients. Methods. We conducted a retrospective review of all patients with coccidioidomycosis who underwent solid organ transplantation at our center to identify factors for recrudescent coccidioidomycosis (despite antifungal prophylaxis) after transplantation. Results. Between June 1999 and June 2009, 100 patients with previous coccidioidomycosis underwent solid organ transplantation at our institution. Ninety-four (94%) received anticoccidioidal prophylaxis after transplantation. The six patients who did not receive such prophylaxis did not experience reactivated coccidioidomycosis. Five patients who received anticoccidioidal prophylaxis experienced reactivated infection. All five patients survived with further antifungal treatment. Among patients who experienced recrudescent infection despite antifungal prophylaxis, African American race was an identified risk factor. Pretransplant dissemination may be a risk factor for reactivated coccidioidomycosis, but this finding was not statistically significant. Whether nonadherence to prophylaxis played a small or large role is uncertain. Conclusions. Antifungal prophylaxis effectively suppressed recrudescent coccidioidomycosis after solid organ transplantation for the large majority of patients with a history of coccidioidomycosis before transplantation. Strict lifelong adherence to antifungal prophylaxis is imperative.
引用
收藏
页码:88 / 93
页数:6
相关论文
共 50 条
  • [1] Antifungal Prophylaxis in Solid Organ Transplant Recipients
    Senol, Sebnem
    Kutsoylu, Oya Eren
    Kaya, Onur
    Avci, Meltem
    Tasbakan, Meltem Isikgoz
    Oguz, Vildan Avkan
    Baysan, Betil Ozhak
    Cavus, Sema Alp
    Cetin, Cigdem Banu
    Ergin, Cagri
    Ertugrul, Bulent
    Kutlu, Selda Sayin
    Kutlu, Murat
    Mermut, Gulsen
    Metin, Dilek Yesim
    Ozturk, Barcin
    Pullukcu, Husnu
    Turhan, Ozge
    Yapar, Nur
    [J]. MEDITERRANEAN JOURNAL OF INFECTION MICROBES AND ANTIMICROBIALS, 2015, 4
  • [2] Antifungal prophylaxis in solid organ transplant recipients
    Brizendine, Kyle D.
    Vishin, Sonia
    Baddley, John W.
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2011, 9 (05) : 571 - 581
  • [3] Coccidioidomycosis in solid organ transplant recipients
    Nanayakkara, Deepa D.
    Blodget, Emily
    [J]. CURRENT OPINION IN ORGAN TRANSPLANTATION, 2019, 24 (04) : 465 - 468
  • [4] EPICO 3.0. Antifungal prophylaxis in solid organ transplant recipients
    Zaragoza, Rafael
    Maria Aguado, Jose
    Ferrer, Ricard
    Rodriguez, Alejandro H.
    Maseda, Emilio
    Llinares, Pedro
    Grau, Santiago
    Munoz, Patricia
    Fortun, Jesus
    Bouzada, Mercedes
    Carlos del Pozo, Juan
    Leon, Rafael
    [J]. REVISTA IBEROAMERICANA DE MICOLOGIA, 2016, 33 (04): : 187 - 195
  • [5] Antifungal prophylaxis for solid organ transplant recipients: Seeking clarity amidst controversy
    Singh, N
    [J]. CLINICAL INFECTIOUS DISEASES, 2000, 31 (02) : 545 - 553
  • [6] Diagnostic Approach to Coccidioidomycosis in Solid Organ Transplant Recipients
    Zangeneh, Tirdad T. T.
    Al-Obaidi, Mohanad M. M.
    [J]. JOURNAL OF FUNGI, 2023, 9 (05)
  • [7] Antifungal prophylaxis in solid-organ transplant recipients: Considerations for clinical trial design
    Singh, N
    [J]. CLINICAL INFECTIOUS DISEASES, 2004, 39 : S200 - S206
  • [8] Cytomegalovirus prophylaxis in solid organ transplant recipients
    Patel, R
    Snydman, DR
    Rubin, RH
    Ho, M
    Pescovitz, M
    Martin, M
    Paya, CV
    [J]. TRANSPLANTATION, 1996, 61 (09) : 1279 - 1289
  • [9] The Utility of Diagnostic Testing for Active Coccidioidomycosis in Solid Organ Transplant Recipients
    Mendoza, N.
    Blair, J. E.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (04) : 1034 - 1039
  • [10] Cytomegalovirus prophylaxis in solid organ transplant recipients: The issues
    Legendre, C
    Thervet, E
    [J]. TRANSPLANTATION PROCEEDINGS, 2000, 32 (02) : 377 - 378